These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3080860)

  • 21. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of flecainide.
    Conard GJ; Ober RE
    Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
    Lévy RH; Lévy S; Bricaud H
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects of class I antiarrhythmic agents.
    Legrand V; Collignon P
    Drugs; 1985; 29 Suppl 4():54-7. PubMed ID: 3924551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 26. New directions in antiarrhythmic drug therapy.
    Somberg JC
    Am J Cardiol; 1984 Aug; 54(4):8B-17B. PubMed ID: 6147082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics in heart failure. An updated review.
    Shammas FV; Dickstein K
    Clin Pharmacokinet; 1988 Aug; 15(2):94-113. PubMed ID: 3064953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congestive heart failure induced by six of the newer antiarrhythmic drugs.
    Ravid S; Podrid PJ; Lampert S; Lown B
    J Am Coll Cardiol; 1989 Nov; 14(5):1326-30. PubMed ID: 2509529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
    Mehvar R; Brocks DR; Vakily M
    Clin Pharmacokinet; 2002; 41(8):533-58. PubMed ID: 12102640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy of cardiac arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Cardiol Clin; 1983 May; 1(2):305-22. PubMed ID: 6443562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
    Vanhaleweyk G; Serruys PW; Hugenholtz PG
    Eur Heart J; 1984 Sep; 5 Suppl B():67-74. PubMed ID: 6437819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of some antiarrhythmic drugs.
    Ochs HR; Greenblatt DJ; Bodem G
    Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiarrhythmic drugs.
    Hillis WS; Whiting B
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1332-6. PubMed ID: 6132656
    [No Abstract]   [Full Text] [Related]  

  • 37. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 39. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
    Horowitz LN; Morganroth J
    J Am Coll Cardiol; 1987 Feb; 9(2):459-63. PubMed ID: 3100601
    [No Abstract]   [Full Text] [Related]  

  • 40. Tocainide kinetics in congestive heart failure.
    Mohiuddin SM; Esterbrooks D; Hilleman DE; Aronow WS; Patterson AJ; Sketch MH; Mooss AN; Hee TT; Reich JW
    Clin Pharmacol Ther; 1983 Nov; 34(5):596-603. PubMed ID: 6414753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.